Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Humacyte, Inc. Director's Dealing 2024

Jun 3, 2024

33410_dirs_2024-06-03_37991972-9cb7-4994-82b3-9bc170b1bbeb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2024-05-30

Reporting Person: Prichard Heather Ledbetter (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-30 Common Stock S 61941 $7.71 Disposed 2625 Direct
2024-05-30 Common Stock M 78779 $2.56 Acquired 81404 Direct
2024-05-30 Common Stock S 78779 $8.36 Disposed 2625 Direct
2024-05-30 Common Stock M 48166 $3.07 Acquired 50791 Direct
2024-05-30 Common Stock S 48166 $8.32 Disposed 2625 Direct
2024-05-31 Common Stock S 2625 $9.412 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-30 Stock Options (right to buy) $2.56 M 78779 Disposed 2025-12-11 Common Stock (78779) Direct
2024-05-30 Stock Options (right to buy) $3.07 M 48166 Disposed 2032-12-08 Common Stock (48166) Direct

Footnotes

F1: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.36 to $8.44. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.31 to $8.42. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.